Viewing StudyNCT06496373



Ignite Creation Date: 2024-07-17 @ 11:14 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06496373
Status: RECRUITING
Last Update Posted: 2024-07-11
First Post: 2024-06-18

Brief Title: Clinical Study of XP-004 Personalized mRNA Tumor Vaccine Combined With PD-1 Inhibitor for Postoperative Adjuvant Therapy for Pancreatic Cancer in Patients With Advanced Solid Tumors
Sponsor: Ruijin Hospital
Organization: Ruijin Hospital

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer Recurrent
Keywords:
Name View
Personalized View
Neoantigen View
Pancreatic cancer View
Post-operative prevention View